FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793669508> ?p ?o ?g. }

• W2793669508 endingPage "e25090" @default.
• W2793669508 startingPage "e25090" @default.
• W2793669508 abstract "Introduction UNAIDS 90-90-90 targets and Fast-Track commitments are presented as precursors to ending the AIDS epidemic by 2030, through effecting a 90% reduction in new HIV infections and AIDS-related deaths from 2010 levels (HIV epidemic control). Botswana, a low to middle-income country with the third-highest HIV prevalence, and Australia, a low-prevalence high-income country with an epidemic concentrated among men who have sex with men (MSM), have made significant strides towards achieving the UNAIDS 90-90-90 targets. These two countries provide lessons for different epidemic settings. This paper discusses the lessons that can be drawn from Botswana and Australia with respect to their success in HIV testing, treatment, viral suppression and other HIV prevention strategies for HIV epidemic control. Discussion Botswana and Australia are on target to achieving the 90-90-90 targets for HIV epidemic control, made possible by comprehensive HIV testing and treatment programmes in the two countries. As of 2015, 70% of all people assumed to be living with HIV had viral suppression in Botswana and Australia. However, HIV incidence remains above one per cent in the general population in Botswana and in MSM in Australia. The two countries have demonstrated that rapid HIV testing that is accessible and targeted at key and vulnerable populations is required in order to continue identifying new HIV infections. All citizens living with HIV in both countries are eligible for antiretroviral therapy (ART) and viral load monitoring through government-funded programmes. Notwithstanding their success in reducing HIV transmission to date, programmes in both countries must continue to be supported at current levels to maintain epidemic suppression. Scaled HIV testing, linkage to care, universal ART, monitoring patients on treatment over and above strengthened HIV prevention strategies (e.g. male circumcision and pre-exposure prophylaxis) will all continue to require funding. Conclusions The progress that Botswana and Australia have made towards meeting the 90-90-90 targets is commendable. However, in order to reduce HIV incidence significantly towards 2030, there is a need for sustained HIV testing, linkage to care and high treatment coverage. Botswana and Australia provide useful lessons for developing countries with generalized epidemics and high-income countries with concentrated epidemics." @default.
• W2793669508 created "2018-03-29" @default.
• W2793669508 creator A5003824090 @default.
• W2793669508 creator A5010048599 @default.
• W2793669508 creator A5013176250 @default.
• W2793669508 creator A5026400798 @default.
• W2793669508 creator A5026518567 @default.
• W2793669508 creator A5032863083 @default.
• W2793669508 creator A5060048120 @default.
• W2793669508 creator A5067026202 @default.
• W2793669508 creator A5071119117 @default.
• W2793669508 creator A5079344044 @default.
• W2793669508 creator A5080445365 @default.
• W2793669508 creator A5087142790 @default.
• W2793669508 date "2018-03-01" @default.
• W2793669508 modified "2023-10-11" @default.
• W2793669508 title "A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and Australia" @default.
• W2793669508 cites W1933429737 @default.
• W2793669508 cites W1993996194 @default.
• W2793669508 cites W2181860342 @default.
• W2793669508 cites W2239032355 @default.
• W2793669508 cites W2310218779 @default.
• W2793669508 cites W2331612363 @default.
• W2793669508 cites W2346436652 @default.
• W2793669508 cites W2511343380 @default.
• W2793669508 cites W2522268324 @default.
• W2793669508 cites W2529978077 @default.
• W2793669508 cites W2558856494 @default.
• W2793669508 cites W2604609286 @default.
• W2793669508 cites W2766416891 @default.
• W2793669508 cites W4242220952 @default.
• W2793669508 cites W4253061993 @default.
• W2793669508 doi "https://doi.org/10.1002/jia2.25090" @default.
• W2793669508 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5838412" @default.
• W2793669508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29508945" @default.
• W2793669508 hasPublicationYear "2018" @default.
• W2793669508 type Work @default.
• W2793669508 sameAs 2793669508 @default.
• W2793669508 citedByCount "23" @default.
• W2793669508 countsByYear W27936695082018 @default.
• W2793669508 countsByYear W27936695082019 @default.
• W2793669508 countsByYear W27936695082020 @default.
• W2793669508 countsByYear W27936695082021 @default.
• W2793669508 countsByYear W27936695082022 @default.
• W2793669508 countsByYear W27936695082023 @default.
• W2793669508 crossrefType "journal-article" @default.
• W2793669508 hasAuthorship W2793669508A5003824090 @default.
• W2793669508 hasAuthorship W2793669508A5010048599 @default.
• W2793669508 hasAuthorship W2793669508A5013176250 @default.
• W2793669508 hasAuthorship W2793669508A5026400798 @default.
• W2793669508 hasAuthorship W2793669508A5026518567 @default.
• W2793669508 hasAuthorship W2793669508A5032863083 @default.
• W2793669508 hasAuthorship W2793669508A5060048120 @default.
• W2793669508 hasAuthorship W2793669508A5067026202 @default.
• W2793669508 hasAuthorship W2793669508A5071119117 @default.
• W2793669508 hasAuthorship W2793669508A5079344044 @default.
• W2793669508 hasAuthorship W2793669508A5080445365 @default.
• W2793669508 hasAuthorship W2793669508A5087142790 @default.
• W2793669508 hasBestOaLocation W27936695081 @default.
• W2793669508 hasConcept C119599485 @default.
• W2793669508 hasConcept C127413603 @default.
• W2793669508 hasConcept C138816342 @default.
• W2793669508 hasConcept C138885662 @default.
• W2793669508 hasConcept C142462285 @default.
• W2793669508 hasConcept C144024400 @default.
• W2793669508 hasConcept C149923435 @default.
• W2793669508 hasConcept C159047783 @default.
• W2793669508 hasConcept C159110408 @default.
• W2793669508 hasConcept C162324750 @default.
• W2793669508 hasConcept C2776939746 @default.
• W2793669508 hasConcept C2776983459 @default.
• W2793669508 hasConcept C2778137410 @default.
• W2793669508 hasConcept C2908647359 @default.
• W2793669508 hasConcept C2993143319 @default.
• W2793669508 hasConcept C3013748606 @default.
• W2793669508 hasConcept C41895202 @default.
• W2793669508 hasConcept C50522688 @default.
• W2793669508 hasConcept C71924100 @default.
• W2793669508 hasConcept C761482 @default.
• W2793669508 hasConcept C83864248 @default.
• W2793669508 hasConcept C99454951 @default.
• W2793669508 hasConceptScore W2793669508C119599485 @default.
• W2793669508 hasConceptScore W2793669508C127413603 @default.
• W2793669508 hasConceptScore W2793669508C138816342 @default.
• W2793669508 hasConceptScore W2793669508C138885662 @default.
• W2793669508 hasConceptScore W2793669508C142462285 @default.
• W2793669508 hasConceptScore W2793669508C144024400 @default.
• W2793669508 hasConceptScore W2793669508C149923435 @default.
• W2793669508 hasConceptScore W2793669508C159047783 @default.
• W2793669508 hasConceptScore W2793669508C159110408 @default.
• W2793669508 hasConceptScore W2793669508C162324750 @default.
• W2793669508 hasConceptScore W2793669508C2776939746 @default.
• W2793669508 hasConceptScore W2793669508C2776983459 @default.
• W2793669508 hasConceptScore W2793669508C2778137410 @default.
• W2793669508 hasConceptScore W2793669508C2908647359 @default.
• W2793669508 hasConceptScore W2793669508C2993143319 @default.
• W2793669508 hasConceptScore W2793669508C3013748606 @default.
• W2793669508 hasConceptScore W2793669508C41895202 @default.

• next